The number of people with susceptibility test result for rifampicin in Philippines
Philippines: The number of people with susceptibility test result for rifampicin was 111,868 in 2021. ◆ Volatile
Latest (2021)
111,868
Change on year
up 35.5%
World rank
6th
of 155 countries
All-time high
111,868
in 2021
All-time low
1,027
in 2018
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in Philippines, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for the number of people with susceptibility test result for rifampicin in Philippines is 111,868, measured in 2021. That is the highest value across all 5 years on record.
Compared with earlier readings it is up 35.5% on the previous year and up 320.5% over five years.
That places Philippines 6th out of 155 countries with data for 2021, putting it in the top 10%.
The number of people with susceptibility test result for rifampicin in Philippines, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 26,602 | — |
| 2018 | 1,027 | -96.1% |
| 2019 | 68,866 | +6605.6% |
| 2020 | 82,547 | +19.9% |
| 2021 | 111,868 | +35.5% |
Philippines compared with similar countries
- Philippines's 111,868 is above the median for upper middle income countries, which is 880, 127.1× the median. (46 countries reporting)
- Philippines's 111,868 is above the median for East Asia & Pacific, which is 185, 604.7× the median. (28 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 32,165 | 1,027 | 68,866 | 3 |
| 2020s | 97,208 | 82,547 | 111,868 | 2 |
Countries ranked near Philippines
More health data for Philippines
- Un projection of annual infant deaths, annual growth rate -1.24 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5317 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,456 deaths per 1,000 people (2090)
- Number of infants who die before age 1 7,006 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 89 (2025)
- Population ages 00-04, female, annual growth rate -2.61 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.037 units per person (2025)
- Population ages 00-04, male, annual growth rate -2.21 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in Philippines?
- The number of people with susceptibility test result for rifampicin in Philippines was 111,868 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in Philippines?
- The highest recorded value was 111,868 in 2021.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in Philippines?
- The lowest recorded value was 1,027 in 2018.
- How does Philippines rank for the number of people with susceptibility test result for rifampicin?
- Philippines ranks 6th out of 155 countries with data for 2021.
- Where does this Philippines data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).